Yi Chen
Stock Analyst at HC Wainwright & Co.
(3.57)
# 865
Out of 5,090 analysts
502
Total ratings
42.12%
Success rate
8.03%
Average return
Main Sectors:
Stocks Rated by Yi Chen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BLTE Belite Bio | Maintains: Buy | $98 → $185 | $143.38 | +29.03% | 22 | Dec 1, 2025 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $19 | $12.46 | +52.49% | 29 | Nov 25, 2025 | |
| BLFS BioLife Solutions | Reiterates: Buy | $32 | $25.76 | +24.22% | 4 | Nov 24, 2025 | |
| BNGO Bionano Genomics | Maintains: Buy | $11 → $7 | $1.69 | +314.20% | 3 | Nov 24, 2025 | |
| DRTS Alpha Tau Medical | Reiterates: Buy | $9 | $3.94 | +128.43% | 21 | Nov 24, 2025 | |
| CODX Co-Diagnostics | Reiterates: Neutral | n/a | $0.37 | - | 24 | Nov 24, 2025 | |
| LFMD LifeMD | Maintains: Buy | $13 → $9 | $3.55 | +153.88% | 11 | Nov 19, 2025 | |
| VNRX VolitionRx | Maintains: Buy | $2.5 → $1.5 | $0.33 | +359.84% | 4 | Nov 17, 2025 | |
| VVOS Vivos Therapeutics | Initiates: Buy | $7 | $2.10 | +233.33% | 1 | Nov 17, 2025 | |
| BRNS Barinthus Biotherapeutics | Maintains: Buy | $3 → $4 | $0.75 | +434.76% | 14 | Nov 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $54 → $36 | $21.75 | +65.52% | 6 | Nov 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $3.25 | +115.38% | 5 | Nov 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $64 → $69 | $46.55 | +48.23% | 7 | Nov 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $42 | $20.90 | +100.96% | 17 | Nov 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $98 → $89 | $76.67 | +16.08% | 3 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $1.75 | +185.71% | 2 | Nov 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $16 → $17 | $17.15 | -0.87% | 20 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $26 | $33.46 | -22.30% | 2 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $2 → $2.5 | $0.69 | +262.32% | 23 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $34 | $13.05 | +160.54% | 13 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.86 | - | 24 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $2.03 | +244.61% | 14 | Sep 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.84 | +44.78% | 20 | Sep 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $10 | $4.56 | +119.30% | 5 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $2.05 | +387.80% | 17 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.43 | +179.72% | 7 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $1.63 | +452.15% | 2 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $12 → $8 | $3.88 | +106.19% | 20 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $23 | $17.32 | +32.79% | 23 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.97 | - | 24 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.08 | +270.37% | 7 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $16 | $13.56 | +17.99% | 11 | Jul 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $18 | $16.67 | +7.98% | 1 | May 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $25 | $18.71 | +33.62% | 12 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $38 → $39 | $8.96 | +335.27% | 8 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3 | $1.35 | +123.05% | 14 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3 | $0.60 | +398.17% | 1 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $2.53 | +1,085.77% | 20 | Jan 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.19 | - | 10 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $500 | $3.25 | +15,298.83% | 5 | May 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $0.14 | +7,900.00% | 14 | Feb 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $58 → $48 | $11.33 | +323.84% | 8 | Apr 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $19 | $106.14 | -82.10% | 2 | Feb 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $0.88 | - | 2 | Apr 16, 2020 |
Belite Bio
Dec 1, 2025
Maintains: Buy
Price Target: $98 → $185
Current: $143.38
Upside: +29.03%
Ocular Therapeutix
Nov 25, 2025
Reiterates: Buy
Price Target: $19
Current: $12.46
Upside: +52.49%
BioLife Solutions
Nov 24, 2025
Reiterates: Buy
Price Target: $32
Current: $25.76
Upside: +24.22%
Bionano Genomics
Nov 24, 2025
Maintains: Buy
Price Target: $11 → $7
Current: $1.69
Upside: +314.20%
Alpha Tau Medical
Nov 24, 2025
Reiterates: Buy
Price Target: $9
Current: $3.94
Upside: +128.43%
Co-Diagnostics
Nov 24, 2025
Reiterates: Neutral
Price Target: n/a
Current: $0.37
Upside: -
LifeMD
Nov 19, 2025
Maintains: Buy
Price Target: $13 → $9
Current: $3.55
Upside: +153.88%
VolitionRx
Nov 17, 2025
Maintains: Buy
Price Target: $2.5 → $1.5
Current: $0.33
Upside: +359.84%
Vivos Therapeutics
Nov 17, 2025
Initiates: Buy
Price Target: $7
Current: $2.10
Upside: +233.33%
Barinthus Biotherapeutics
Nov 17, 2025
Maintains: Buy
Price Target: $3 → $4
Current: $0.75
Upside: +434.76%
Nov 14, 2025
Maintains: Buy
Price Target: $54 → $36
Current: $21.75
Upside: +65.52%
Nov 13, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.25
Upside: +115.38%
Nov 12, 2025
Maintains: Buy
Price Target: $64 → $69
Current: $46.55
Upside: +48.23%
Nov 11, 2025
Maintains: Buy
Price Target: $36 → $42
Current: $20.90
Upside: +100.96%
Nov 7, 2025
Maintains: Buy
Price Target: $98 → $89
Current: $76.67
Upside: +16.08%
Nov 3, 2025
Reiterates: Buy
Price Target: $5
Current: $1.75
Upside: +185.71%
Oct 31, 2025
Maintains: Buy
Price Target: $16 → $17
Current: $17.15
Upside: -0.87%
Oct 30, 2025
Maintains: Buy
Price Target: $25 → $26
Current: $33.46
Upside: -22.30%
Oct 7, 2025
Maintains: Buy
Price Target: $2 → $2.5
Current: $0.69
Upside: +262.32%
Oct 7, 2025
Reiterates: Buy
Price Target: $34
Current: $13.05
Upside: +160.54%
Sep 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.86
Upside: -
Sep 23, 2025
Reiterates: Buy
Price Target: $7
Current: $2.03
Upside: +244.61%
Sep 11, 2025
Reiterates: Buy
Price Target: $7
Current: $4.84
Upside: +44.78%
Sep 4, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $4.56
Upside: +119.30%
Sep 2, 2025
Reiterates: Buy
Price Target: $10
Current: $2.05
Upside: +387.80%
Sep 2, 2025
Reiterates: Buy
Price Target: $4
Current: $1.43
Upside: +179.72%
Sep 2, 2025
Reiterates: Buy
Price Target: $9
Current: $1.63
Upside: +452.15%
Aug 12, 2025
Maintains: Buy
Price Target: $12 → $8
Current: $3.88
Upside: +106.19%
Aug 6, 2025
Maintains: Buy
Price Target: $22 → $23
Current: $17.32
Upside: +32.79%
Aug 1, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.97
Upside: -
Jul 29, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.08
Upside: +270.37%
Jul 16, 2025
Reiterates: Buy
Price Target: $16
Current: $13.56
Upside: +17.99%
May 28, 2025
Initiates: Buy
Price Target: $18
Current: $16.67
Upside: +7.98%
May 5, 2025
Reiterates: Neutral
Price Target: $25
Current: $18.71
Upside: +33.62%
Apr 21, 2025
Maintains: Buy
Price Target: $38 → $39
Current: $8.96
Upside: +335.27%
Apr 7, 2025
Reiterates: Buy
Price Target: $3
Current: $1.35
Upside: +123.05%
Mar 31, 2025
Initiates: Buy
Price Target: $3
Current: $0.60
Upside: +398.17%
Jan 2, 2025
Reiterates: Buy
Price Target: $30
Current: $2.53
Upside: +1,085.77%
Nov 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.19
Upside: -
May 17, 2024
Reiterates: Buy
Price Target: $500
Current: $3.25
Upside: +15,298.83%
Feb 21, 2024
Reiterates: Buy
Price Target: $11
Current: $0.14
Upside: +7,900.00%
Apr 22, 2022
Maintains: Neutral
Price Target: $58 → $48
Current: $11.33
Upside: +323.84%
Feb 17, 2021
Maintains: Buy
Price Target: $18 → $19
Current: $106.14
Upside: -82.10%
Apr 16, 2020
Downgrades: Neutral
Price Target: n/a
Current: $0.88
Upside: -